Investment demonstrates confidence in America’s commitment to science and innovation WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic competitiveness across the life sciences sector. As one of […]

Partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel application and assay development Cambridge, UK: CN Bio, a leading provider of Organ-on-a-chip systems and solutions that accelerate drug discovery and development workflows, today announced the establishment of a strategic partnership with Pharmaron, a premier R&D service provider for the life sciences industry. Under […]

ADC assay now available through ABS; customer study proves IO60 is a spatial workhorse MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, today announced the availability of a new assay designed to advance antibody-drug conjugate (ADC) development in breast cancer. The new assay will be featured alongside customer-generated real-world data from […]

>8,500 samples and 100 million cells of high resolution and fully annotated spatial proteomics data available MARLBOROUGH, Mass. — Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, and Enable Medicine, a real-world data company providing AI-ready patient, cellular and molecular data, today announced a groundbreaking collaboration to deliver the largest commercially available single-cell spatial […]

A Compact Benchtop Optofluidic System with Lower Cost of Ownership for Broader Research Accessibility EMERYVILLE, Calif. — Bruker Corporation (Nasdaq: BRKR) today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025. This new Beacon benchtop system offers an accessible entry point into live single-cell functional analysis. Beacon […]

Early Access Partnership with Dr. Nigel Jamieson to Explore 3D Spatial Biology in Oncology Research BOSTON — Stellaromics, a pioneer in 3D spatial biology, today announced that Dr. Nigel Jamieson and his team at the University of Glasgow are the first European users of the company’s Pyxa platform. As an inaugural early access partner, Dr. Jamieson, a physician-scientist and Professor at the University of […]

FOSTER CITY, Calif. and DURHAM, N.C. — 1Cell.Ai, a global leader in single cell precision diagnostics, has joined forces with BioSkryb Genomics, a pioneer in single cell multi-omics, to co-develop and commercialize next-generation single cell multi-omic solutions. This collaboration will empower researchers and clinicians to detect and characterize rare mutations in single cells with unprecedented accuracy, facilitating breakthroughs in cancer […]

New relationships with Cold Spring Biotech, SCRUM and DaonBS in APAC will enable many more laboratories to adopt Syncell technology TAIPEI, Taiwan & LIVERMORE, Calif. — Syncell, a leader in next-generation subcellular protein purification and spatial proteomics analysis, announced the launch of their preferred partner network today. The company’s commercial expansion includes new services partners […]

Durham, NC – EpiCypher®, a leader in epigenomics innovation, announces the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery. These tools build upon EpiCypher’s proven CUT&RUN platform – a targeted nuclease strategy that has revolutionized chromatin profiling by enabling high-resolution mapping […]

Expanded suite of consumables, instruments and services designed to empower researchers and accelerate next-generation drug development Ninety posters and presentations at AACR powered by the Standard BioTools proteomic portfolio to advance cancer research from target discovery to clinical development SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (NASDAQ: LAB) today announced the launch of new and enhanced […]